IRCT2012100611022N1已完成未知
Comparison of the effects of valsartan versus sildenafil on pulmonary arterial pressure in thalassemia major and intermedia patients with pulmonary hypertension
School of medicine- Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10 years 至 100 years（—）
- 性别
- All
入选标准
- •thalassemia intermedia or major, age = 10 years, systolic pulmonary artery pressure = mmhg25.
- •Exclusion criteria: Allergy to sildenafil or valsartan, incidence the side effects of drugs, no consent to continue the study, using other drugs which are in interaction with study drugs, increased NYHA function class of dyspnea
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Clinical effect of telmisartan versus valsartan on blood pressure during anesthesiaDiseases of the circulatory systemKCT0001595Konkuk University Medical Center300
已完成
3 期
The effect of Valsartan and Amlodipine combination with two different forms in controlling 24-hour ambulatory blood presureEssential Hypertension.Essential (primary) hypertensionIRCT20221016056199N1Shiraz University of Medical Sciences136
已完成
不适用
Effect of sacubitril/valsartan versus valsartan on blood pressure in hypertensive patients with chronic heart failure and chronic kidney disease, a parallel-group randomized controlled trialHypertension with chronic heart failure and chronic kidney diseaseJPRN-UMIN000043657Yokohama City University Medical Center62
已完成
不适用
Efficacy and Safety of Valsartan and Aliskiren Combination Therapy in Patients with Diabetic Nephropathy and HypertensioType 2 diabetes with nephropathy and hypertensionJPRN-UMIN000003741Kansai Medical University80
进行中（未招募）
不适用
Efficacy and safety of a medicine containing the active substance valsartan, or a medicine (fixed-dose combination) containing the two active substances valsartan and hydrochlorothiazide in the treatment of patients with high blood pressure.Patients with mild to moderate arterial hypertension.MedDRA version: 14.1Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2012-005129-57-SIKrka, d.d., Novo mesto500